Biotech

All Articles

Galapagos pauses CAR-T cell therapy trial over Parkinsonism instance

.Galapagos has paused application in a test of a BCMA-directed CAR-T cell treatment, pushing the bra...

James Wilson leaving Penn to introduce 2 new biotechs

.After more than three decades, gene therapy pioneer James Wilson M.D., Ph.D., is leaving behind the...

3 biotechs try to defeat the summer months warm through shedding team

.As biotechs attempt to turn a fresh page in August, a minimum of 3 firms have actually lost workers...

venBio lifts $528M for 5th lifestyle sciences VC fund

.Veteran venture capital firm venBio has actually raised one more half a billion dollars to invest i...

Otsuka spends $800M for Jnana as well as its clinical-stage PKU medication

.Otsuka Pharmaceutical has grabbed Boston-based Jnana Therapies for $800 thousand so the Eastern bio...

FibroGen gives up 75% of US personnel as property fails 2 even more tests

.FibroGen is significantly restructuring its organization, laying off 75% of its united state worker...

Tracon relax full weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has actually made a decision to wind down operations full weeks after an inj...

Ideaya bags choice on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually wagering $400 thousand in biobucks that a bispecific antibody-drug c...

Takeda takes $140M reduction on stopped working epilepsy medication, touts FDA run

.Our company presently recognize that Takeda is wanting to discover a pathway to the FDA for epileps...

VBI Vaccinations apply for insolvency, finds asset purchase

.Immunology biotech VBI Vaccinations is actually veering precariously near the moment of truth, alon...